SCHEMBL7400531

SCHEMBL7400531

CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)N([N+]=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ELANE P08246 17/20 0.47
XIAP P98170 2/20 0.44
CTSG P08311 1/20 0.41
SLC6A2 P23975 1/20 0.41
MLX Q9UH92 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8662695 0.86 ELANE (0.45) ELANEXIAPCTSGMLX
SCHEMBL7351756 0.85 TACR1 (0.52) SLC6A2
SCHEMBL7410732 0.83 ELANE (0.43) ELANEXIAPMLX
SCHEMBL8182012 0.82 ACE (0.44)
SCHEMBL10895690 0.79 ELANE (0.42) ELANE
SCHEMBL7213508 0.78 TACR1 (0.49) XIAPSLC6A2
SCHEMBL29758603 0.78 XIAP (0.62) ELANEXIAP
SCHEMBL5494650 0.77 ELANE (0.40) ELANEXIAPMLX
SCHEMBL8660922 0.77 ELANE (0.39) ELANE
SCHEMBL24056573 0.76 CFD (0.56) XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212300-A1 AZACYCLOALKANONE SERINE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-06-12 EP disclosed
WO-2001019795-A1 AZACYCLOALKANONE SERINE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed